Investors Sell Johnson & Johnson (JNJ) on Strength (JNJ)

Investors sold shares of Johnson & Johnson (NYSE:JNJ) on strength during trading on Friday. $180.60 million flowed into the stock on the tick-up and $255.41 million flowed out of the stock on the tick-down, for a money net flow of $74.81 million out of the stock. Of all stocks tracked, Johnson & Johnson had the 0th highest net out-flow for the day. Johnson & Johnson traded up $1.92 for the day and closed at $133.15

JNJ has been the topic of several analyst reports. BTIG Research reaffirmed a “sell” rating and set a $110.00 price target on shares of Johnson & Johnson in a research note on Wednesday, January 24th. Vetr downgraded shares of Johnson & Johnson from a “buy” rating to a “hold” rating and set a $147.40 price target on the stock. in a research note on Monday, January 8th. Credit Suisse Group set a $154.00 price target on shares of Johnson & Johnson and gave the stock a “hold” rating in a research note on Monday, January 22nd. BMO Capital Markets lifted their price target on shares of Johnson & Johnson to $161.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 12th. Finally, Wells Fargo & Co reaffirmed an “outperform” rating and set a $160.00 price target (up previously from $155.00) on shares of Johnson & Johnson in a research note on Friday, January 12th. Four investment analysts have rated the stock with a sell rating, eight have given a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. Johnson & Johnson currently has a consensus rating of “Hold” and a consensus price target of $146.16.

The firm has a market cap of $357,710.13, a price-to-earnings ratio of 341.41, a price-to-earnings-growth ratio of 2.23 and a beta of 0.74. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.32 and a quick ratio of 1.02.

Johnson & Johnson (NYSE:JNJ) last announced its quarterly earnings data on Tuesday, January 23rd. The company reported $1.74 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.72 by $0.02. The company had revenue of $20.20 billion during the quarter, compared to analyst estimates of $20.08 billion. Johnson & Johnson had a net margin of 1.70% and a return on equity of 27.80%. The firm’s revenue for the quarter was up 11.5% compared to the same quarter last year. During the same period last year, the business earned $1.58 EPS. sell-side analysts predict that Johnson & Johnson will post 8.11 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 13th. Shareholders of record on Tuesday, February 27th will be issued a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a yield of 2.52%. The ex-dividend date is Monday, February 26th. Johnson & Johnson’s dividend payout ratio is currently 861.54%.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Parkwood LLC lifted its position in Johnson & Johnson by 63.6% in the 2nd quarter. Parkwood LLC now owns 50,873 shares of the company’s stock valued at $6,730,000 after purchasing an additional 19,776 shares during the last quarter. Mechanics Bank Trust Department lifted its position in Johnson & Johnson by 0.5% in the 2nd quarter. Mechanics Bank Trust Department now owns 89,965 shares of the company’s stock valued at $11,902,000 after purchasing an additional 412 shares during the last quarter. Kwmg LLC lifted its position in Johnson & Johnson by 7.0% in the 2nd quarter. Kwmg LLC now owns 14,781 shares of the company’s stock valued at $1,955,000 after purchasing an additional 964 shares during the last quarter. Meridian Wealth Management LLC lifted its position in Johnson & Johnson by 1.2% in the 2nd quarter. Meridian Wealth Management LLC now owns 12,641 shares of the company’s stock valued at $1,672,000 after purchasing an additional 149 shares during the last quarter. Finally, Lederer & Associates Investment Counsel CA lifted its position in Johnson & Johnson by 6.5% in the 2nd quarter. Lederer & Associates Investment Counsel CA now owns 20,067 shares of the company’s stock valued at $2,655,000 after purchasing an additional 1,225 shares during the last quarter. 65.53% of the stock is owned by institutional investors and hedge funds.

WARNING: This report was first posted by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this report on another website, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this report can be viewed at https://stocknewstimes.com/2018/02/18/investors-sell-johnson-johnson-jnj-on-strength-jnj.html.

Johnson & Johnson Company Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply